STAT3 and neoplasm: We further demonstrate that inhibition of STAT3 by siRNA-mediated knockdown or a small molecule inhibitor S3I-201 universally sensitized trastuzumab-resistant cells to trastuzumab treatment and significantly suppressed tumor growth in vitro and in vivo.